Q&A: What role does corneal hysteresis play in determining glaucoma risk?

Video

Thomas A. Wong, OD, FNAP, and his co-authors Elise Regina, OD, and Kelly Armstrong, OD, discuss corneal hysteresis: part three.

Ahead of his technology article in the July 2022 issue of Optometry Times®, Thomas A. Wong, OD, FNAP, associate clinical professor of SUNY Optometry, and his co-authors Elise Regina, OD, and Kelly Armstrong, OD, both members of the SUNY Optometry class of 2022, discuss corneal hysteresis.

Related: Q&A: What is corneal hysteresis?

This transcript has been lightly edited for clarity:

What role does corneal hysteresis play in determining glaucoma risk?

Elise Regina, OD:

So the current risk factors that we all know right now..., the main five are old age, high IOP, CD ratio, high pattern standard deviation, and a thinner central corneal thickness. And also things that we consider in clinic include race, family history, the quality of the testing that we're getting and how long the patient has been followed for these things.

Related: Q&A: How is corneal hysteresis measured?

So earlier intervention is always better for these glaucoma patients, especially to prevent any permanent damage or vision loss. So when we're talking about corneal hysteresis, it just can be another one of all of these factors that we take into account when we're diagnosing and monitoring our patients for progression.

It's still unclear how exactly corneal hysteresis is related to glaucoma. But it also may be a new independent risk factor for glaucoma that we as practitioners can use when we're diagnosing and treating our patients. Since the corneal hysteresis doesn't directly affect the IOP measurements the way the central corneal thickness does, it makes the association with the IOP minimal, which is a good thing for us.

Related: Corneal hysteresis and biomechanics growing in diagnostic importance

So this literature is hypothesizing that the hysteresis may be a biomarker for the biomechanical properties of these tissues, and therefore the low corneal hysteresis readings would increase the risk for glaucomatous damage with IOP peaks and fluctuations.

Recent Videos
Ali Tafreshi sits down with Optometry Times to discuss Topcon's "Healthcare from the Eye" initiative.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
Mile Brujic, OD, FAAO; Nate Lighthizer, OD, FAAO; Brianna Rhue, OD, FAAO, FSLS; Ben Casella, OD; and Ben Gaddie, OD, FAAO shared their insights from the conference.
Dr. Nate Lighthizer shares key takeaways from the SECO Showcase on anterior segment technology and full laser certification course offered at SECO.
Shan Lin, MD, and John Berdahl, MD, share their perspectives as ophthalmologists regarding the importance of comanagement.
Robert L. Stamper, MD, overviews his optometric track talk titled Objective Perimetry - Can you see it? at this year's Glaucoma 360 meeting.
Dr. Julie Rodman previews her SECO presentations
Three EnVision Summit faculty members weigh in on the importance of comanagement in glaucoma management, where artificial intelligence will lead eye care, and what hopes are on the horizon for corneal ectasia treatments.
Yvonne Ou, MD, outlined lifestyle modifications for glaucoma management that have proven beneficial, including yoga and cycling.
Robert L. Stamper, MD, weighs in on what he think more optometrists should know about glaucoma and current misconceptions concerning glaucoma testing.
© 2025 MJH Life Sciences

All rights reserved.